The TGFBeta pathway as a therapeutic target in cancer.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Joan Seoane

Abstract

The TGFBeta pathway has recently emerged as a putative therapeutic target against cancer. However, TGFBeta has a complex and dual role in cancer. In normal epithelial cells and early tumours, TGFBeta acts as a tumour suppressor. In contrast, during tumour progression TGFBeta becomes an oncogenic factor inducing proliferation, angiogenesis, invasion and metastasis, as well as suppressing the anti-tumoral immune response. The role of TGFBeta in oncogenesis requires the precise understanding of the TGFBeta pathway in order to design optimal therapeutic approaches and select the patient population that may benefit from an anti-TGFBeta therapy. Here we review the rationale for evaluating TGFBeta signalling inhibitors as cancer therapeutics, and the progress made in the preclinical and clinical testing of anti- TGFBeta compounds.

References

Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A B KulkarniS Karlsson
Mar 10, 2000·Cytokine & Growth Factor Reviews·K M Mulder
Oct 5, 2001·Nature Genetics·R DerynckA Balmain
Jan 16, 2002·Current Opinion in Genetics & Development·Lalage M Wakefield, Anita B Roberts
Oct 11, 2002·The Journal of Biological Chemistry·Gareth J Inman, Caroline S Hill
Dec 17, 2002·Journal of Cell Science·Justin P AnnesDaniel B Rifkin
Jun 18, 2003·Cell·Yigong Shi, Joan Massagué
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Ariela BenigniGiuseppe Remuzzi
Jul 5, 2003·Cancer Cell·Nancy Dumont, Carlos L Arteaga
Jul 29, 2003·Investigative Ophthalmology & Visual Science·Anna L MeadPeng T Khaw
Oct 15, 2003·Nature Reviews. Cancer·Peter M Siegel, Joan Massagué
May 8, 2004·Trends in Biochemical Sciences·Peter ten Dijke, Caroline S Hill
Jul 6, 2004·Nature Genetics·Takeshi MizuguchiNaomichi Matsumoto
Sep 29, 2004·Molecular and Cellular Endocrinology·Stephanie A Pangas, Martin M Matzuk
Dec 2, 2004·Nature Reviews. Drug Discovery·Jonathan M YinglingJ Scott Sawyer
Aug 18, 2005·Journal of Cell Science·Aristidis Moustakas, Carl-Henrik Heldin
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Xin-Hua Feng, Rik Derynck
Nov 29, 2005·Cytokine & Growth Factor Reviews·Laurence Levy, Caroline S Hill
Dec 3, 2005·Genes & Development·Joan MassaguéDavid Wotton
Dec 27, 2005·Cytokine & Growth Factor Reviews·Karl-Hermann SchlingensiepenPiotr Jachimczak
May 16, 2006·Carcinogenesis·Joan Seoane
Jun 24, 2006·Nature Reviews. Cancer·Brian Bierie, Harold L Moses
Nov 15, 2006·Current Cancer Drug Targets·Elise F Saunier, Rosemary J Akhurst
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen H WrzesinskiRichard A Flavell

❮ Previous
Next ❯

Citations

Jan 13, 2010·The Journal of Experimental Medicine·Sara I CunhaKristian Pietras
Sep 26, 2012·The Journal of Clinical Investigation·Libing SongJun Li
Nov 28, 2013·World Journal of Gastroenterology : WJG·Chuan-Li RenHui Chen
Jan 7, 2010·Journal of Oncology·Zhuo Georgia Chen
Dec 12, 2012·Cell Stem Cell·Naoki Oshimori, Elaine Fuchs
Jan 10, 2017·Journal of Clinical Medicine·Brunella CostanzaAndrei Turtoi
May 18, 2011·Oncogene·G MaurerM Baccarini
Feb 25, 2009·Expert Opinion on Therapeutic Targets·Elisabeth JonesNatasha Kyprianou
Jan 9, 2010·Expert Opinion on Therapeutic Targets·Kerrilyn R DienerJohn D Hayball
Apr 7, 2017·EMBO Reports·Sarah Kit Leng LuiPieter Johan Adam Eichhorn
Jun 15, 2016·International Journal of Cancer. Journal International Du Cancer·Elisenda Alsina-SanchisFrancesc Viñals
Jun 5, 2020·Integrative Cancer Therapies·Ghada A El TawiilHebatallah E Mohamed
Sep 25, 2014·Science China. Life Sciences·FangFang ZhouLong Zhang
Jul 3, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Esther BertranIsabel Fabregat
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·De'Broski R HerbertFred D Finkelman
Aug 3, 2014·Cancer Discovery·Laura RodónJoan Seoane
Dec 2, 2008·Biochemical Pharmacology·Simona SerratìMario Del Rosso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Current Cancer Drug Targets
Elise F Saunier, Rosemary J Akhurst
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Manav Korpal, Yibin Kang
© 2021 Meta ULC. All rights reserved